Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Molbio Diagnostics Limited (NSE: MOLBIO), ISIN INE869T01028 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MOLBIO last traded at ₹1438.60 (-2.74%), with a 52-week range of ₹925.80 to ₹1686.50 (as of 9 Oct 2026).
Shareholding as of Sep 2026: promoters 41.29%, FIIs 1.51%, DIIs 16.36%, mutual funds 2.25%.
EquiSense Score (ECS): 69/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.